Marketing Authorization (MA) procedures in light of the EU Pharmaceutical Legislation Reform

Join us as we unravel the historical legislative changes that have shaped the pharmaceutical industry and explore the visionary future pharmaceutical strategy for Europe. Delve into the upcoming reform of EU pharmaceutical legislation, understanding its objectives, timelines, and impact on the EU Marketing Authorization (MA) regulatory framework. Discover how the planned changes will impact expectations regarding compliance with legislation requirements imposed on Marketing Authorization Holders, covering various aspects of MA such as new procedural improvements and simplifications, as well as dossier or pharmacovigilance information. This webinar aims to provide a comprehensive and concise overview of the expected changes to the European strategic approach, ensuring you stay ahead in navigating the evolving pharmaceutical landscape.